Alessio Ardizzone

Alessio Ardizzone obtained his Master’s Degree in Pharmaceutical Chemistry and Technology in  2019 and his PhD in Applied Biology and Experimental Medicine in 2022 at the University of  Messina. He also completed two Second-Level University Master’s Degrees: in 2024, in  “Pharmacovigilance: Safety Monitoring, Risk Management, Quality Assurance in the Digital Health  Era” at the University of Milan, and in 2025, in “Techniques for the Preparation of Antineoplastic  Drugs and Assessment of the Safety and Efficacy of Medical Devices” at the University of Messina. 

He carried out international research activities at the Institute of Infection, Immunity and  Inflammation of the University of Glasgow as an Affiliate Researcher, focusing on  immunopharmacology and the pharmacology of inflammatory processes. 

In 2025, he obtained the Italian National Scientific Qualification for the position of Associate  Professor in sector 05/G1 “Pharmacology, Clinical Pharmacology and Pharmacognosy”, currently  corresponding to GSD BIOS-11/A. 

Since 1 September 2026, he has been Associate Professor of Pharmacology at UniCamillus – Saint  Camillus International University of Health Sciences, where he had previously served as a Tenure Track Researcher. Before joining UniCamillus, he was a Fixed-Term Researcher (RTD-A) and a  Research Fellow at the University of Messina. 

He currently teaches Pharmacology in the Medicine and Surgery and Medicine & Surgery degree  programmes. 

His scientific activity primarily focuses on the pharmacology of inflammatory and  neuroinflammatory processes, neurodegenerative diseases, and oncology, with particular interest in  the identification of novel pharmacological targets and biomarkers. He has participated in national  and interdisciplinary research projects, including PRIN 2020, PRIN 2022, Liver Smart Drug (LSD),  and ANTHEM (AdvaNced Technology for Human centEred Medicine). His scientific output  currently includes more than 70 publications in international journals, with a Scopus h-index of 22  and over 1,200 citations. 

His awards and distinctions include a Young Fellowship from the Italian Society of Pharmacology,  the SIF-Farmindustria Award for Pharmacological Research, the “Fondazione Celeghin” Award from  the Italian Association of Neuro-Oncology, and, in 2026, the SIF “Paolo Preziosi” Award, dedicated  to outstanding young researchers under the age of 38 in the field of pharmacology. 

He also serves as a reviewer for several international scientific journals and is a member of the Early  Career Editorial Board of Nutrients. 

He is a member of several national and international scientific societies, including the Italian Society  of Pharmacology (SIF) and the British Pharmacological Society (BPS).